Therapeutic challenges and management of heart failure during pregnancy (part 2)

Medical Science Monitor

Volumn 18, Issue 6, 2012, Pages

  Kryczka, Karolina ^a   Dzielińska, Zofia ^a   Przybylski, Andrzej ^a   Szczudlik, Julia ^b   Dangel, Joanna ^b   Konka, Marek ^a   Czajkowski, Krzysztof ^b   Rózański, Jacek ^a   Bilińska, Zofia T ^a   Demkow, Marcin ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Dilated cardiomyopathy; Heart failure; Heart failure treatment in pregnancy; Pregnancy

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DIGITALIS; FUROSEMIDE; METOPROLOL; SPIRONOLACTONE;

ARTICLE; BRADYCARDIA; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CONGESTIVE CARDIOMYOPATHY; DEFIBRILLATOR; FEMINIZATION; FIRST TRIMESTER PREGNANCY; GOITER; HEART ARREST; HEART DEATH; HEART FAILURE; HUMAN; HYPERBILIRUBINEMIA; HYPERTHYROIDISM; HYPOTHYROIDISM; INTRAUTERINE GROWTH RETARDATION; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MORBIDITY; OLIGOHYDRAMNIOS; PERIPARTUM CARDIOMYOPATHY; PHENOTYPE; POLYCYTHEMIA; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; PROGRESSION FREE SURVIVAL; SECOND TRIMESTER PREGNANCY; STROKE; TACHYCARDIA; TRANSIENT ISCHEMIC ATTACK; TREATMENT INDICATION;

EID: 84863552363     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.882859     Document Type: Article

References (15)

1. Tanous D, Siu SC, Mason J et al: B-type natriuretic peptide in pregnant women with heart disease. J Am Coll Cardiol, 2010; 56: 1247-53
2. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C et al: ESC Guidelines on the management of cardiovascular diseases during pregnancy. Eur Heart J, 2011; 32: 3147-97
3. Elliott P, Andersson B, Arbustini E et al: Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy; Eur J Heart Fail, 2010; 12: 767-78
4. Howlett JG, McKelvie RS, Costigan J et al: The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs. Can J Cardiol, 2010; 26(4): 185-202
5. Siu SC, Sermer M, Colman JM et al: Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation, 2001; 104: 515-21
6. Goland S, Bitar F, Modi K et al: Evaluation of the Clinical Relevance of Baseline Left Ventricular Ejection Fraction as a Predictor of Recovery or Persistence of Severe Dysfunction in Women in the United States With Peripartum Cardiomyopathy. J Card Fail; 2011; 17(5): 426-30
7. Grewal J, Siu SC, Ross HJ et al: Pregnancy outcomes in women with dilated cardiomyopathy. J Am Coll Cardiol, 2009; 55(1): 45-52
8. Chow T, Galvin J, McGovern B: Antiarrhythmic drug therapy in pregnancy and lactation. Am J Cardiol, 1998; 82(4A): 58I-62I
9. Cooper WO, Hernandez-Diaz S, Arbogast PG et al: Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med, 2006; 354: 2443-51
10. Shotan A, Widerhorn J, Hurst A, Elkayam U: Risks of angiotensin-converting enzyme inhibition during pregnancy Am J Med, 1994; 96: 451-56
11. Alwan S, Polifka JE, Friedman JM: Angiotensin II receptor antagonist treatment during pregnancy. Clin Mol Teratol, 2005; 73(2): 123-30
12. Sekine T, Miura K, Takahashi K, Igarashi T: Children's toxicology from bench to bed--Drug-induced renal injury (1): The toxic effects of ARB/ACEI on fetal kidney development. J Toxicol Sci, 2009; 34(Suppl.2): SP245-50
13. Tabacova S, Little R, Tsong Y et al: Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment. Pharmacoepidemiol Drug Saf, 2003; 12(8): 633-46
14. Kron J, Conti JB: Arrhythmias in the pregnant patient: Current concepts in evaluation and management. J Interv Card Electrophysiol, 2007; 19: 95-107
15. Elkayam U: Clinical Characteristics of Peripartum Cardiomyopathy in the United States. J Am Coll Cardiol, 2011; 58(7): 659-70